Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00315_DB00752_nanopub.RAQ8nu31gN4xYjc2NVKRU3U2LQ4oY2mzHK-j-eccfvcH4#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00315_DB00752 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00315_DB00752 label "DDI between Zolmitriptan and Tranylcypromine - The MAO inhibitor, tranylcypromine, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing tranylcypromine are contraindicated. [drugbank_resource:DB00315_DB00752]" assertion.
- drugbank_resource:DB00315_DB00752 identifier "drugbank_resource:DB00315_DB00752" assertion.
- drugbank_resource:DB00315_DB00752 title "DDI between Zolmitriptan and Tranylcypromine - The MAO inhibitor, tranylcypromine, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing tranylcypromine are contraindicated." assertion.
- drugbank:DB00752 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00752 assertion.
- drugbank:DB00315 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00752 assertion.